Tasmar Overdose: An Introduction
Tasmar® (
tolcapone) is a prescription
Parkinson's disease medication. It belongs to a group of medications known as catechol-O-methyltransferase (COMT) inhibitors. As with any medication, it is possible to take too much Tasmar. The specific effects of a Tasmar overdose can vary, depending on a number of factors, including the
Tasmar dosage and whether it was taken with any other medications or substances.
Symptoms of a Tasmar Overdose
In studies, when high doses of Tasmar were given to humans and animals, it caused the following symptoms:
- Nausea
- Vomiting
- Dizziness
- Difficulty breathing.
It is important to remember that Tasmar is always used in combination with
carbidopa and levodopa products (such as
Sinemet®,
Sinemet CR, or
Parcopa®). If a person has overdosed on Tasmar, it is likely that an overdose with carbidopa and levodopa may have also occurred
(see Sinemet Overdose for more information).
Treatment for a Tasmar Overdose
The treatment for a Tasmar overdose may also vary, and there is no known antidote. If the overdose was recent, a healthcare provider may "pump the stomach" or administer certain medications to induce vomiting or to absorb the medication from the digestive tract. Dialysis is not expected to be useful for removing Tasmar from the blood. Treatment may also involve supportive care, which consists of treating the symptoms that occur as a result of the overdose. For example, supportive treatment options may include:
- Careful monitoring of the heart, blood pressure, and breathing
- Fluids through an intravenous line (IV)
- Other treatments based on complications that occur.
It is important that you seek medical attention immediately if you believe you may have overdosed on Tasmar.